Global and United States RNAi for Therapeutic In-Depth Research Report 2017-2022

August 2017 | 128 pages | ID: GD8CC205CF2EN
US Market Insights (UMI)

Abstracts

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in RNAi for Therapeutic industry.

Major Companies

• Alnylam Pharmaceuticals (USA)
• Arbutus Biopharma (Tekmira) (Canada)
• Arrowhead Research (USA)
• Dicerna Pharmaceuticals (USA)
• Mirna Therapeutics (USA)
• Quark Pharmaceuticals (Israel)
• RXi Pharmaceuticals (USA)
• Silence Therapeutics (Germany)
• Benitec Biopharma (Australia)
• miRagen Therapeutics (USA)
• Sylentis (Spain)
• Gradalis (USA)
• Sirnaomics (USA)
• Silenseed (Israel)
• Arcturus Therapeutics (USA)
• Arcturus Therapeutics (USA)
• Ariz Biopharma (USA)
• GeneCopoeia (USA)
• Ascletis Pharmaceuticals (USA)
• Celsion Corporation (USA)
• Astellas Pharma (USA)
• AstraZeneca (UK)
• BioSpring (Vietnam)
• Calando Pharmaceuticals (USA)
• Celgene (USA)
• Bayer Heathcare (USA)
• Biogazelle (Belgium)
• CombiMatrix (USA)
• Creative Animodel (USA)
• Ensysce Biosciences (USA)

Key Regions

• North America
• United States
• California
• Texas
• New York
• Others
• Canada
• Latin America
• Mexico
• Brazil
• Argentina
• Others
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherland
• Others
• Asia & Pacific
• China
• Japan
• India
• Korea
• Australia
• Southeast Asia
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Others
• Africa & Middle East
• South Africa
• Egypt
• Turkey
• Saudi Arabia
• Iran
• Others

Main types of products

RNAi for Therapeutic Market, by Technology

• siRNA
• miRNA
• shRNA

RNAi for Therapeutic Market, by Molecular Form

• Single Chain
• Double Chain

RNAi for Therapeutic Market, by Key Consumers

• Cancer
• Cardiovascular
• HBV
• Other

Contents

Global and United States RNAi for Therapeutic In-Depth Research Report 2017-2022

CHAPTER ONE GLOBAL RNAI FOR THERAPEUTIC MARKET OVERVIEW

1.1 Global RNAi for Therapeutic Market Sales Volume Revenue and Price 2012-2017
1.2 RNAi for Therapeutic, by Technology 2012-2017
  1.2.1 Global RNAi for Therapeutic Sales Market Share by Technology 2012-2017
  1.2.2 Global RNAi for Therapeutic Revenue Market Share by Technology 2012-2017
  1.2.3 Global RNAi for Therapeutic Price by Technology 2012-2017
  1.2.4 siRNA
  1.2.5 miRNA
  1.2.6 shRNA
1.3 RNAi for Therapeutic, by Molecular Form 2012-2017
  1.3.1 Global RNAi for Therapeutic Sales Market Share by Molecular Form 2012-2017
  1.3.2 Global RNAi for Therapeutic Revenue Market Share by Molecular Form 2012-2017
  1.3.3 Global RNAi for Therapeutic Price by Molecular Form 2012-2017
  1.3.4 Single Chain
  1.3.5 Double Chain

CHAPTER TWO UNITED STATES RNAI FOR THERAPEUTIC MARKET OVERVIEW

2.1 United States RNAi for Therapeutic Market Sales Volume Revenue and Price 2012-2017
2.2 RNAi for Therapeutic, by Technology 2012-2017
  2.2.1 United States RNAi for Therapeutic Sales Market Share by Technology 2012-2017
  2.2.2 United States RNAi for Therapeutic Revenue Market Share by Technology 2012-2017
  2.2.3 United States RNAi for Therapeutic Price by Technology 2012-2017
  2.2.4 siRNA
  2.2.5 miRNA
  2.2.6 shRNA
2.3 RNAi for Therapeutic, by Molecular Form 2012-2017
  2.3.1 United States RNAi for Therapeutic Sales Market Share by Molecular Form 2012-2017
  2.3.2 United States RNAi for Therapeutic Revenue Market Share by Molecular Form 2012-2017
  2.3.3 United States RNAi for Therapeutic Price by Molecular Form 2012-2017
  2.3.4 Single Chain
  2.3.5 Double Chain

CHAPTER THREE RNAI FOR THERAPEUTIC BY REGIONS 2012-2017

3.1 Global RNAi for Therapeutic Sales Market Share by Regions 2012-2017
3.2 Global RNAi for Therapeutic Revenue Market Share by Regions 2012-2017
3.3 Global RNAi for Therapeutic Price by Regions 2012-2017
3.4 North America
  3.4.1 United States
    3.4.1.1 California
    3.4.1.2 Texas
    3.4.1.3 New York
    3.4.1.4 Others in United States
  3.4.2 Canada
3.5 Latin America
  3.5.1 Mexico
  3.5.2 Brazil
  3.5.3 Argentina
  3.5.4 Others in Latin America
3.6 Europe
  3.6.1 Germany
  3.6.2 United Kingdom
  3.6.3 France
  3.6.4 Italy
  3.6.5 Spain
  3.6.6 Russia
  3.6.7 Netherland
  3.6.8 Others in Europe
3.7 Asia & Pacific
  3.7.1 China
  3.7.2 Japan
  3.7.3 India
  3.7.4 Korea
  3.7.5 Australia
  3.7.6 Southeast Asia
    3.7.6.1 Indonesia
    3.7.6.2 Thailand
    3.7.6.3 Philippines
    3.7.6.4 Vietnam
    3.7.6.5 Singapore
    3.7.6.6 Malaysia
    3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
  3.8.1 South Africa
  3.8.2 Egypt
  3.8.3 Turkey
  3.8.4 Saudi Arabia
  3.8.5 Iran
  3.8.6 Others in Africa & Middle East

CHAPTER FOUR GLOBAL RNAI FOR THERAPEUTIC BY COMPANIES 2012-2017

4.1 Global RNAi for Therapeutic Sales Volume Market Share by Companies 2012-2017
4.2 Global RNAi for Therapeutic Revenue Share by Companies 2012-2017
4.3 Global Top Companies RNAi for Therapeutic Key Product Model and Market Performance
4.4 Global Top Companies RNAi for Therapeutic Key Target Consumers and Market Performance

CHAPTER FIVE UNITED STATES RNAI FOR THERAPEUTIC BY COMPANIES 2012-2017

5.1 United States RNAi for Therapeutic Sales Volume Market Share by Companies 2012-2017
5.2 United States RNAi for Therapeutic Revenue Share by Companies 2012-2017
5.3 United States Top Companies RNAi for Therapeutic Key Product Model and Market Performance
5.4 United States Top Companies RNAi for Therapeutic Key Target Consumers and Market Performance

CHAPTER SIX GLOBAL RNAI FOR THERAPEUTIC BY CONSUMER 2012-2017

6.1 Global RNAi for Therapeutic Sales Market Share by Consumer 2012-2017
6.2 Cancer
6.3 Cardiovascular
6.4 HBV
6.5 Other
6.6 Consuming Habit and Preference

CHAPTER SEVEN GLOBAL RNAI FOR THERAPEUTIC BY CONSUMER 2012-2017

7.1 Global RNAi for Therapeutic Sales Market Share by Consumer 2012-2017
7.2 Cancer
7.3 Cardiovascular
7.4 HBV
7.5 Other
7.6 Consuming Habit and Preference

CHAPTER EIGHT TOP COMPANIES PROFILE

8.1 Alnylam Pharmaceuticals (USA)
  8.1.1 Alnylam Pharmaceuticals (USA) Company Details and Competitors
  8.1.2 Alnylam Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
  8.1.3 Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
  8.1.4 Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
8.2 Arbutus Biopharma (Tekmira) (Canada)
  8.2.1 Arbutus Biopharma (Tekmira) (Canada) Company Details and Competitors
  8.2.2 Arbutus Biopharma (Tekmira) (Canada) Key RNAi for Therapeutic Models and Performance
  8.2.3 Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Business SWOT Analysis and Forecast
  8.2.4 Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
8.3 Arrowhead Research (USA)
  8.3.1 Arrowhead Research (USA) Company Details and Competitors
  8.3.2 Arrowhead Research (USA) Key RNAi for Therapeutic Models and Performance
  8.3.3 Arrowhead Research (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
  8.3.4 Arrowhead Research (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
8.4 Dicerna Pharmaceuticals (USA)
  8.4.1 Dicerna Pharmaceuticals (USA) Company Details and Competitors
  8.4.2 Dicerna Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
  8.4.3 Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
  8.4.4 Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
8.5 Mirna Therapeutics (USA)
  8.5.1 Mirna Therapeutics (USA) Company Details and Competitors
  8.5.2 Mirna Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
  8.5.3 Mirna Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
  8.5.4 Mirna Therapeutics (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
8.6 Quark Pharmaceuticals (Israel)
  8.6.1 Quark Pharmaceuticals (Israel) Company Details and Competitors
  8.6.2 Quark Pharmaceuticals (Israel) Key RNAi for Therapeutic Models and Performance
  8.6.3 Quark Pharmaceuticals (Israel) RNAi for Therapeutic Business SWOT Analysis and Forecast
  8.6.4 Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
8.7 RXi Pharmaceuticals (USA)
  8.7.1 RXi Pharmaceuticals (USA) Company Details and Competitors
  8.7.2 RXi Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
  8.7.3 RXi Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
  8.7.4 RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
8.8 Silence Therapeutics (Germany)
  8.8.1 Silence Therapeutics (Germany) Company Details and Competitors
  8.8.2 Silence Therapeutics (Germany) Key RNAi for Therapeutic Models and Performance
  8.8.3 Silence Therapeutics (Germany) RNAi for Therapeutic Business SWOT Analysis and Forecast
  8.8.4 Silence Therapeutics (Germany) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
8.9 Benitec Biopharma (Australia)
  8.9.1 Benitec Biopharma (Australia) Company Details and Competitors
  8.9.2 Benitec Biopharma (Australia) Key RNAi for Therapeutic Models and Performance
  8.9.3 Benitec Biopharma (Australia) RNAi for Therapeutic Business SWOT Analysis and Forecast
  8.9.4 Benitec Biopharma (Australia) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
8.10 miRagen Therapeutics (USA)
  8.10.1 miRagen Therapeutics (USA) Company Details and Competitors
  8.10.2 miRagen Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
  8.10.3 miRagen Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
  8.10.4 miRagen Therapeutics (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
8.11 Sylentis (Spain)
8.12 Gradalis (USA)
8.13 Sirnaomics (USA)
8.14 Silenseed (Israel)
8.15 Arcturus Therapeutics (USA)
8.16 Arcturus Therapeutics (USA)
8.17 Ariz Biopharma (USA)
8.18 GeneCopoeia (USA)
8.19 Ascletis Pharmaceuticals (USA)
8.20 Celsion Corporation (USA)
8.21 Astellas Pharma (USA)
8.22 AstraZeneca (UK)
8.23 BioSpring (Vietnam)
8.24 Calando Pharmaceuticals (USA)
8.25 Celgene (USA)
8.26 Bayer Heathcare (USA)
8.27 Biogazelle (Belgium)
8.28 CombiMatrix (USA)
8.29 Creative Animodel (USA)
8.30 Ensysce Biosciences (USA)

CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN

9.1 RNAi for Therapeutic Industry Chain Structure
  9.1.1 R&D
  9.1.2 Raw Materials (Components)
  9.1.3 Manufacturing Plants
  9.1.4 Regional Trading (Import Export and Local Sales)
  9.1.5 Online Sales Channel
  9.1.6 Offline Channel
  9.1.7 End Users
9.2 RNAi for Therapeutic Manufacturing
  9.2.1 Key Components
  9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment

CHAPTER TEN GLOBAL RNAI FOR THERAPEUTIC MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

10.1 Global RNAi for Therapeutic Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
10.2 Global RNAi for Therapeutic Sales (K Pcs) Forecast by Regions (2017-2022)
10.3 Global RNAi for Therapeutic Sales (K Pcs) Forecast by Application (2017-2022)
10.4 Global RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
10.5 Global RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)

CHAPTER ELEVEN UNITED STATES RNAI FOR THERAPEUTIC MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 United States RNAi for Therapeutic Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 United States RNAi for Therapeutic Sales (K Pcs) Forecast by Regions (2017-2022)
11.3 United States RNAi for Therapeutic Sales (K Pcs) Forecast by Application (2017-2022)
11.4 United States RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
11.5 United States RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)

CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION

12.1 Development Trend
12.2 Research Conclusion

CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Table Global RNAi for Therapeutic Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global RNAi for Therapeutic Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table Global RNAi for Therapeutic Sales (K Pcs) by Technology (2012-2017)
Table Global RNAi for Therapeutic Sales Market Share by Technology (2012-2017)
Figure Global RNAi for Therapeutic Sales Market Share by Technology in 2016
Table Global RNAi for Therapeutic Revenue (Million USD) by Technology (2012-2017)
Table Global RNAi for Therapeutic Revenue Market Share by Technology (2012-2017)
Figure Global RNAi for Therapeutic Revenue Market Share by Technology in 2016
Table Global RNAi for Therapeutic Price (USD/Pcs) by Technology (2012-2017)
Table Top Companies of siRNA RNAi for Therapeutic Products List
Figure Global siRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of miRNA RNAi for Therapeutic Products List
Figure Global miRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of shRNA RNAi for Therapeutic Products List
Figure Global shRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Global RNAi for Therapeutic Sales (K Pcs) by Molecular Form (2012-2017)
Table Global RNAi for Therapeutic Sales Market Share by Molecular Form (2012-2017)
Figure Global RNAi for Therapeutic Sales Market Share by Molecular Form in 2016
Table Global RNAi for Therapeutic Revenue (Million USD) by Molecular Form (2012-2017)
Table Global RNAi for Therapeutic Revenue Market Share by Molecular Form (2012-2017)
Figure Global RNAi for Therapeutic Revenue Market Share by Molecular Form in 2016
Table Global RNAi for Therapeutic Price (USD/Pcs) by Molecular Form (2012-2017)
Table Top Companies of Single Chain RNAi for Therapeutic Products List
Figure Global Single Chain RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of Double Chain RNAi for Therapeutic Products List
Figure Global Double Chain RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States RNAi for Therapeutic Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table United States RNAi for Therapeutic Sales (K Pcs) by Technology (2012-2017)
Table United States RNAi for Therapeutic Sales Market Share by Technology (2012-2017)
Figure United States RNAi for Therapeutic Sales Market Share by Technology in 2016
Table United States RNAi for Therapeutic Revenue (Million USD) by Technology (2012-2017)
Table United States RNAi for Therapeutic Revenue Market Share by Technology (2012-2017)
Figure United States RNAi for Therapeutic Revenue Market Share by Technology in 2016
Table United States RNAi for Therapeutic Price (USD/Pcs) by Technology (2012-2017)
Table Top Companies of siRNA RNAi for Therapeutic Products List
Figure United States siRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of miRNA RNAi for Therapeutic Products List
Figure United States miRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of shRNA RNAi for Therapeutic Products List
Figure United States shRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table United States RNAi for Therapeutic Sales (K Pcs) by Molecular Form (2012-2017)
Table United States RNAi for Therapeutic Sales Market Share by Molecular Form (2012-2017)
Figure United States RNAi for Therapeutic Sales Market Share by Molecular Form in 2016
Table United States RNAi for Therapeutic Revenue (Million USD) by Molecular Form (2012-2017)
Table United States RNAi for Therapeutic Revenue Market Share by Molecular Form (2012-2017)
Figure United States RNAi for Therapeutic Revenue Market Share by Molecular Form in 2016
Table United States RNAi for Therapeutic Price (USD/Pcs) by Molecular Form (2012-2017)
Table Top Companies of Single Chain RNAi for Therapeutic Products List
Figure United States Single Chain RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of Double Chain RNAi for Therapeutic Products List
Figure United States Double Chain RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Global RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
Table Global RNAi for Therapeutic Sales Share by Regions (2012-2017)
Figure Global RNAi for Therapeutic Sales Market Share by Regions in 2016
Figure Global RNAi for Therapeutic Sales Market Share by Regions in 2017
Table Global RNAi for Therapeutic Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Global RNAi for Therapeutic Revenue Market Share by Regions (2012-2017)
Figure Global RNAi for Therapeutic Revenue Market Share by Regions in 2016
Figure Global RNAi for Therapeutic Revenue Market Share by Regions in 2017
Table Global RNAi for Therapeutic Price (USD/Pcs) by Regions (2012-2017)
Table North America RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
Table North America RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
Figure North America RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table United States RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
Table United States RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
Figure United States RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Latin America RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
Table Latin America RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
Figure Latin America RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Europe RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
Table Europe RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
Figure Europe RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Asia & Pacific RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
Table Asia & Pacific RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Africa & Middle East RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
Table Africa & Middle East RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Global RNAi for Therapeutic Sales Volume (K Pcs) by Major Companies (2012-2017)
Table Global RNAi for Therapeutic Sales Volume Market Share by Major Companies (2012-2017)
Figure Global RNAi for Therapeutic Sales Volume Market Share by Major Companies 2016
Figure Global RNAi for Therapeutic Sales Volume Market Share by Major Companies 2017
Table Global RNAi for Therapeutic Revenue (Million USD) by Major Companies (2012-2017)
Table Global RNAi for Therapeutic Revenue Market Share by Major Companies (2012-2017)
Figure Global RNAi for Therapeutic Revenue Market Share by Major Companies 2016
Figure Global RNAi for Therapeutic Revenue Market Share by Major Companies 2017
Table Global Top Companies Key Product Model and Market Performance
Table Global Top Companies Key Target Consumers and Market Performance
Table United States RNAi for Therapeutic Sales Volume (K Pcs) by Top Companies (2012-2017)
Table United States RNAi for Therapeutic Sales Volume Market Share by Top Companies (2012-2017)
Figure United States RNAi for Therapeutic Sales Volume Market Share by Top Companies 2016
Figure United States RNAi for Therapeutic Sales Volume Market Share by Top Companies 2017
Table United States RNAi for Therapeutic Revenue (Million USD) by Top Companies (2012-2017)
Table United States RNAi for Therapeutic Revenue Market Share by Top Companies (2012-2017)
Figure United States RNAi for Therapeutic Revenue Market Share by Top Companies 2016
Figure United States RNAi for Therapeutic Revenue Market Share by Top Companies 2017
Table United States Top Companies Key Product Model and Market Performance
Table United States Top Companies Key Target Consumers and Market Performance
Table Global RNAi for Therapeutic Sales (K Pcs) by Consumer (2012-2017)
Figure Global RNAi for Therapeutic Sales Market Share by Consumer (2012-2017)
Figure Global RNAi for Therapeutic Sales Market Share by Consumer in 2016
Figure Global Cancer RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Cardiovascular RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global HBV RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Other RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table United States RNAi for Therapeutic Sales (K Pcs) by Consumer (2012-2017)
Figure United States RNAi for Therapeutic Sales Market Share by Consumer (2012-2017)
Figure United States RNAi for Therapeutic Sales Market Share by Consumer in 2016
Figure United States Cancer RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Cardiovascular RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States HBV RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Other RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
Table Alnylam Pharmaceuticals (USA) Company Details and Competitors
Table Alnylam Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
Table Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
Table Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
Table Arbutus Biopharma (Tekmira) (Canada) Company Details and Competitors
Table Arbutus Biopharma (Tekmira) (Canada) Key RNAi for Therapeutic Models and Performance
Table Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Business SWOT Analysis and Forecast
Table Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
Table Arrowhead Research (USA) Company Details and Competitors
Table Arrowhead Research (USA) Key RNAi for Therapeutic Models and Performance
Table Arrowhead Research (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
Table Arrowhead Research (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Arrowhead Research (USA) RNAi for Therapeutic Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Arrowhead Research (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
Figure Arrowhead Research (USA) RNAi for Therapeutic Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Arrowhead Research (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
Table Dicerna Pharmaceuticals (USA) Company Details and Competitors
Table Dicerna Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
Table Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
Table Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
Table Mirna Therapeutics (USA) Company Details and Competitors
Table Mirna Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
Table Mirna Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
Table Mirna Therapeutics (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Mirna Therapeutics (USA) RNAi for Therapeutic Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Mirna Therapeutics (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
Figure Mirna Therapeutics (USA) RNAi for Therapeutic Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Mirna Therapeutics (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
Table Quark Pharmaceuticals (Israel) Company Details and Competitors
Table Quark Pharmaceuticals (Israel) Key RNAi for Therapeutic Models and Performance
Table Quark Pharmaceuticals (Israel) RNAi for Therapeutic Business SWOT Analysis and Forecast
Table Quark Pharmaceuticals (Israel) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
Table RXi Pharmaceuticals (USA) Company Details and Competitors
Table RXi Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
Table RXi Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
Table RXi Pharmaceuticals (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
Table Silence Therapeutics (Germany) Company Details and Competitors
Table Silence Therapeutics (Germany) Key RNAi for Therapeutic Models and Performance
Table Silence Therapeutics (Germany) RNAi for Therapeutic Business SWOT Analysis and Forecast
Table Silence Therapeutics (Germany) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Silence Therapeutics (Germany) RNAi for Therapeutic Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Silence Therapeutics (Germany) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
Figure Silence Therapeutics (Germany) RNAi for Therapeutic Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Silence Therapeutics (Germany) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
Table Benitec Biopharma (Australia) Company Details and Competitors
Table Benitec Biopharma (Australia) Key RNAi for Therapeutic Models and Performance
Table Benitec Biopharma (Australia) RNAi for Therapeutic Business SWOT Analysis and Forecast
Table Benitec Biopharma (Australia) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Benitec Biopharma (Australia) RNAi for Therapeutic Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Benitec Biopharma (Australia) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
Figure Benitec Biopharma (Australia) RNAi for Therapeutic Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Benitec Biopharma (Australia) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
Table miRagen Therapeutics (USA) Company Details and Competitors
Table miRagen Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
Table miRagen Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
Table miRagen Therapeutics (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure miRagen Therapeutics (USA) RNAi for Therapeutic Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure miRagen Therapeutics (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
Figure miRagen Therapeutics (USA) RNAi for Therapeutic Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure miRagen Therapeutics (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
Table Sylentis (Spain) Company Details and Competitors
Table Gradalis (USA) Company Details and Competitors
Table Sirnaomics (USA) Company Details and Competitors
Table Silenseed (Israel) Company Details and Competitors
Table Arcturus Therapeutics (USA) Company Details and Competitors
Table Arcturus Therapeutics (USA) Company Details and Competitors
Table Ariz Biopharma (USA) Company Details and Competitors
Table GeneCopoeia (USA) Company Details and Competitors
Table Ascletis Pharmaceuticals (USA) Company Details and Competitors
Table Celsion Corporation (USA) Company Details and Competitors
Table Astellas Pharma (USA) Company Details and Competitors
Table AstraZeneca (UK) Company Details and Competitors
Table BioSpring (Vietnam) Company Details and Competitors
Table Calando Pharmaceuticals (USA) Company Details and Competitors
Table Celgene (USA) Company Details and Competitors
Table Bayer Heathcare (USA) Company Details and Competitors
Table Biogazelle (Belgium) Company Details and Competitors
Table CombiMatrix (USA) Company Details and Competitors
Table Creative Animodel (USA) Company Details and Competitors
Table Ensysce Biosciences (USA) Company Details and Competitors
Figure Global RNAi for Therapeutic Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global RNAi for Therapeutic Price (USD/Pcs) Trend Forecast (2017-2022)
Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Regions (2017-2022)
Table Global RNAi for Therapeutic Sales Volume Share Forecast by Regions (2017-2022)
Figure Global RNAi for Therapeutic Sales Volume Share Forecast by Regions (2017-2022)
Figure Global RNAi for Therapeutic Sales Volume Share Forecast by Regions in 2022
Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Application in 2022
Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
Figure Global RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Technology in 2022
Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)
Figure Global RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)
Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Molecular Form in 2022
Figure United States RNAi for Therapeutic Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure United States RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States RNAi for Therapeutic Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States RNAi for Therapeutic Sales (K Pcs) Forecast by Regions (2017-2022)
Table United States RNAi for Therapeutic Sales Volume Share Forecast by Regions (2017-2022)
Figure United States RNAi for Therapeutic Sales Volume Share Forecast by Regions (2017-2022)
Figure United States RNAi for Therapeutic Sales Volume Share Forecast by Regions in 2022
Table United States RNAi for Therapeutic Sales (K Pcs) Forecast by Application (2017-2022)
Figure United States RNAi for Therapeutic Sales Volume Market Share Forecast by Application (2017-2022)
Figure United States RNAi for Therapeutic Sales Volume Market Share Forecast by Application in 2022
Table United States RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
Figure United States RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
Figure United States RNAi for Therapeutic Sales Volume Market Share Forecast by Technology in 2022
Table United States RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)
Figure United States RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)
Figure United States RNAi for Therapeutic Sales Volume Market Share Forecast by Molecular Form in 2022